Analysis Of Income And Expense [Abstract]

GenSight Biologics S.A. - Filing #879715

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
5,276,000 EUR
4,394,000 EUR
Material income and expense [abstract]
Research and development expense
22,920,000 EUR
22,386,000 EUR
Finance income (cost)
489,000 EUR
9,079,000 EUR
Selling, general and administrative expense [abstract]
General and administrative expense
7,411,000 EUR
8,006,000 EUR
Revenue and other operating income
7,709,000 EUR
7,440,000 EUR
Operating expense
35,835,000 EUR
32,374,000 EUR
Sales and marketing expense
5,505,000 EUR
1,982,000 EUR
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
215,000 EUR
215,000 EUR
223,000 EUR
223,000 EUR
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
28,617,000 EUR
28,824,000 EUR
207,000 EUR
33,684,000 EUR
331,000 EUR
34,015,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.